TARGET
saveIL-17
Interleukin-17; psoriasis and spondyloarthritis target.
also known as: il17, il-17a, interleukin-17
drugs
0
catalysts
0
news
15
companies
0
Top drugs
no drugs tagged with this interest yet
🐶 Top companies
no companies tagged with this interest yet
Recent catalysts
no catalysts tagged with this interest yet
Recent news
view all →- AbbVie’s skin disease drug lessens abscess burden in Phase 3 but falls below expectationsbiospace · 6d ago
- Ascletis challenges psoriasis field with pill; Invivyd plans Covid filingendpoints · 29d ago
- ai3Bio, built from two biotechs, pursues a different path to an ‘immune reset’biopharma dive · 29d ago
- ai3Bio emerging from stealth to ‘take the gun out of the hands of the immune system’fiercebiotech · 1mo ago
- 6 immunology targets to sustain a mammoth I&I marketbiospace · 1mo ago
- MoonLake’s nanobody boosts all clinical endpoints in phase 3 psoriatic arthritis trialfiercebiotech · 2mo ago
- Fierce Biotech Fundraising Tracker '26: Nouscom nabs $135M series D; Estuary channels $93M series Afiercebiotech · 10mo ago
Data sources
last refreshed 29m ago
Found something off?
comments(0)
5-min edit window · permanent after that